The conversation begins with introductions and an overview of Dr. Wilkens' research examining vitamin D biology across ruminants and other livestock species. It is explained that vitamin D should not be viewed solely as a vitamin but rather as the precursor to a highly regulated steroid hormone system with complex feedback mechanisms that influence numerous physiological processes throughout the body. The panel discusses how activation and regulation of vitamin D metabolism affects livestock health

Colleen Walson-Billin was told she was not eligible to progress in Quality without a science degree, and went on to lead a full GxP Quality function at a biologics startup.Colleen Walson-Billin on building a Quality career without a science degree.In today's episode I was joined by Colleen Walson-Billin, Vice President & Head of GxP Quality & Compliance at Jade Biosciences. I wanted to speak to Colleen because her route into Quality started with a business degree and a role as administrative

Kicking off series 3, next week on Regulatory Voices, I sit down with Victor Paulus Ph.D, a senior regulatory leader with more than 30 years of experience across vaccines, women’s health, biologics and radiopharmaceuticals.Victor has had a fascinating route into Regulatory Affairs, beginning his career in the laboratory and vaccine manufacturing before making the move into Regulatory and eventually leading functions across multiple organisations.In this episode, we discuss:How moving from

Mirum's brelovitug met Phase 3 AZURE-1's virus-plus-ALT endpoint on weekly and every-four-week dosing in chronic hepatitis delta; durable liver outcomes were not shown. Kodiak's Zenkuda and tabirafusp were noninferior to aflibercept 2 mg on vision in wet AMD, and 54% of Zenkuda patients reached a 24-week interval; neither was compared with newer alternatives. 4DMT started Phase 3 testing of 4D-150 in diabetic macular edema, while Roche will return emugrobart rights to Chugai after an obesity trial's

In this episode, Phil is joined by Ben Sherman, Jon Manning and Rike Hanssen to take a fresh look at Nextflow plugins, two years on from the plugin walkthrough in episode 35. They cover what plugins are for: sharing reusable functions across pipelines, hooking into workflow events with observers (e.g., nf-slack notifications for nf-core full-size tests, or carbon footprint tracking with nf-co2footprint), and building custom executors and file systems. Ben explains what changed in Nextflow 25.10: the

CEO Stefanie Fluckiger-Mangual describes the rationale for targeting CPB/p300 and walks us through TOLREMO's recently presented phase 1 data, which had a clean safety profile and showed evidence of anti-tumor activity.

Caroline Vissers, co-founder of Immunectra and a former UCSF faculty member, who walked away from a lab of her own to build a company. Working alongside scientific co-founders Joe DeRisi and Michael Wilson, Caroline is developing blood-based tests capable of detecting autoimmune disease long before a patient ever shows symptoms.In this episode, Caroline shares why she gave up a faculty position most scientists spend a career chasing, how she prepared for the jump with a venture capital course and

In today's ACT Brief, we examine FDA input sought on early-phase ibogaine protocols, why mixed outsourcing models spread faster than oversight infrastructure, and a major partnership for a rare kidney disease treatment.

The scarecrow watches over the field, but does it watch us back? Does it keep the birds away, or does it deter darker fiends from these haunted lands? Join Robert and Joe for a Halloween-season look at the science, culture and folklore of scarecrows.See omnystudio.com/listener for privacy information.

You might imagine that the DNA in your cells has a simple history. But that’s not the entire story. Nearly half of your genome is a wild drama, thanks to a genetic material called transposons that can clip itself out of the DNA sequence, float off, and paste itself somewhere else. While these “jumping genes” may seem pathological, they’re more than just junk. On this episode of The Quanta Podcast, host Hannah Waters speaks with writer Jake Buehler about these unruly genetic fragments and

In this episode, Dr. Lottie chats with Ashley Farmer, LVT. Ashley is a licensed veterinary technician, hospital manager and currently works in an emergency clinic.She shares her journey from being an aspiring zookeeper to getting into vet tech, what the role involves and the skills that make a great vet tech (or nurse)! We also dive into how anyone interested can get into the field, as well as the more negative aspects of the job so you know exactly what to expect. To our aspiring vet techs

Planetterrian Daily🌍 Planetterrian Daily - Science, Longevity & Health Discoveries Young hearts age rapidly when placed in older bodies while older hearts rejuvenate in young recipients. Top 15 Science & Health Discoveries Hearts show rapid biological aging in older recipients — Nature Hearts from young donors aged rapidly inside older recipients. Older hearts became biologically younger inside young recipients. ... Sources: phys.org · nature.com · miragenews.com · x.com AI Disclosure: This

Heather Gay, star of The Real Housewives of Salt Lake City and author of Bad Mormon, tells Michael why she left the Mormon faith, what that decision cost, and how she rebuilt a sense of self and community. They also discussed her role on the show, and:(00:00) Preview(00:46) Why Heather left her faith(03:01) The choice that changed her life(05:35) Why she stayed Mormon for so long(11:15) The cost of trying to be perfect(15:52) Finding belonging after leaving a faith(22:00) Why most people live a

Inflammation is all over our feeds. Influencers claim it’s the reason you're bloated or fatigued, the source of digestive problems and the cause of more serious illnesses like Alzheimer's or cardiovascular disease. But how much of that is scientifically backed, and how viable are the solutions you see on social media? Short Wave talks to immunologist Shruti Naik to separate the health from the hype. Interested in more wellness science? Email us your question at shortwave@npr.org.Support public media

This audio brief covers key developments from Boehringer Ingelheim, Roche, Fresenius and Sanofi, including clinical trial readouts, regulatory and product advancements, and corporate acquisitions.It was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

Building the Autonomous Pharma Factory What happens when artificial intelligence, robotics, IoT, digital twins, and advanced analytics come together to transform pharmaceutical manufacturing? In this episode of Center of Excellence - Pharma 4.0, we explore the evolution from traditional, fragile manufacturing systems to the Autonomous Pharma Factory—a self-optimising, resilient and digitally connected manufacturing environment. In this episode, we explore: Why pharmaceutical manufacturing needs

Today, in partnership with British Heart Foundation (BHF), we take on the world's biggest killer: heart disease. This episode features BHF's Ruth Goss on why this disease kills so many people; Will Watson at the Royal Papworth Hospital in Cambridge on what arterial disease looks like under a microscope; Cathy Shanahan at King's College London on attempts to stop blood vessels from becoming hard and stiff; and BHF's Sonya Babu-Narayan on risk management and heart disease treatment. Like this podcast

*آیا شعر و ادبیات فارسی به رشد خردورزی کمک کرده‌اند یا به تقویت تقدیرگرایی؟ آیا شعر فارسی د‌وره هایی از شکوفایی و انحطاط رو از سر گذرانده؟* در بخش اول این سری گفتگوها از پادکست هشیوار، با حضوری جمعی از پژوهشگران و صاحب‌نظران برجسته، به نقد و ارزیابی نقش شعر و ادبیات کلاسیک فارسی در شکل‌گیری خرد نقاد، آزادی اندیشه، سنجش باورها و نقد قدرت می‌پردازیم. ادبیات فارسی به‌عنوان مهم‌ترین رکن هویت فرهنگی ایرانیان، همواره نقشی ژرف بر شیوه اندیشیدن و جهان‌بینی ما داشته است. اما آیا این میراث ارزشمند بیشت...

Biotech loves talk of disruptive technology, but few have repeatedly shifted the industry's direction. This episode of the Smart Biotech Scientist Podcast focuses on an idea once dismissed as a fool's game: process intensification through perfusion—now the backbone of leading biomanufacturing platforms. Meet John Bonham-Carter, a serial entrepreneur whose fingerprints are on some of biotech's most transformative tools. From putting the once-ignored ATF system and perfusion on the global stage...

Send us Fan Mail Europe looks like one market on a map, but try bringing a drug across borders and you quickly learn it behaves like many systems at once. We sit down with Daphne Smyth, a regulatory leader based in Ireland with 35+ years in pharmaceutical regulatory affairs, to unpack a mistake we keep seeing: companies build commercial teams first, then discover they have not built the regulatory pathway needed to launch at all. The result is not just delay, it is avoidable rework in clinica...